Montreal, Canada

Arnaud Bonnefoy

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: National Institute of Health and Medical Research. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Arnaud Bonnefoy. Retrieved from https://idiyas.com/inventor/arnaud-bonnefoy

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Arnaud Bonnefoy: Innovator in Cell Preparation Techniques

Introduction

Arnaud Bonnefoy is a notable inventor based in Montreal, Canada. He has made significant contributions to the field of medical research, particularly in the preparation of progenitor cells for engraftment. His innovative approach has the potential to enhance the effectiveness of cell therapies.

Latest Patents

Arnaud Bonnefoy holds a patent titled "Method for preparing cells for engraftment." This invention relates to an in vitro method for preparing progenitor cells that exhibit increased adhesivity. The method involves contacting progenitor cells with an agonist of the CD47/IAP receptor, resulting in progenitor cells that present enhanced adhesivity. He has 1 patent to his name.

Career Highlights

Arnaud Bonnefoy is affiliated with the National Institute of Health and Medical Research, where he conducts research aimed at improving cell therapy techniques. His work focuses on advancing the understanding of cell behavior and enhancing the efficacy of medical treatments.

Collaborations

Arnaud collaborates with Olivier Blanc-Brude, contributing to the advancement of research in their field. Their combined efforts aim to push the boundaries of current medical practices.

Conclusion

Arnaud Bonnefoy's innovative methods in cell preparation represent a significant advancement in medical research. His contributions have the potential to improve patient outcomes in cell therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…